TRAF6 also plays a vital role in tumor glycolysis by mediating Akt ubiquitination, leading to enhanced Akt activation and increased HIF-1α-mediated transcription of hexokinase-2, thereby increasing tumor glycolysis in primary non-small cell lung cancer (NSCLC) 107. Here, TRAF6 is linked to non-small cell lung carcinoma.